EBI

Repurposing drugs to manage Covid-19 progression

Researchers from the University of Cambridge and European Molecular Biology Laboratory’s European Bioinformatics Institute (EMBL-EBI) have used a large-scale human genetics study to identify drug targets important for managing Covid-19 in its early stages.

Subscribe to RSS - EBI